Puma Biotechnology Inc
PBYI
NASDAQ
Biotechnology
$8.83
USD
+0.12 (+1.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $454.88M
Volume 232.9K
Revenue
$231.24M
TTM
-2.9%
YoY
Gross Margin
75%
TTM
+3.5%
YoY
Net Income
$26.72M
TTM
-44.9%
YoY
Operating Cash Flow
$41.15M
TTM
-7.2%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 52.4 | 54.5 | 75.5 | 44.8 | 56.5 |
YoY Growth | +11.4% | -32.4% | +27.7% | -2.6% | +7.8% |
Cost of Revenue | 12.3 | 12.2 | 23.1 | 10.4 | 12.5 |
Gross Profit | 40.1 | 42.3 | 52.3 | 34.4 | 44.0 |
Selling, General & Administrative | 18.0 | 16.8 | 18.4 | 18.4 | 17.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 33.5 | 32.7 | 35.2 | 38.2 | 36.4 |
Operating Income | 6.6 | 9.6 | 17.1 | -3.8 | 7.6 |
EBITDA | 9.4 | 12.3 | 19.8 | -1.2 | 10.1 |
Other Income / Expense | 0.4 | 0.1 | 0.1 | 0.1 | 0.0 |
Total Other Income / Expense | -0.5 | -0.3 | 0.0 | 0.4 | 0.7 |
Income Before Income Taxes | 6.2 | 9.2 | 17.1 | -3.4 | 8.2 |
Income Taxes | 0.3 | 0.4 | 3.7 | 0.3 | 0.1 |
Net Income | 5.9 | 8.8 | 13.4 | -3.8 | 8.2 |
Consolidated Net Income / Loss | 5.9 | 8.8 | 13.4 | -3.8 | 8.2 |
Net Income Attributable to Common Shareholders | 5.9 | 8.8 | 13.4 | -3.8 | 8.2 |
Basic EPS | $0.12 | $0.18 | $0.27 | -$0.07 | $0.16 |
Diluted EPS | $0.12 | $0.17 | $0.26 | -$0.07 | $0.16 |
Basic Shares Outstanding | 49.7M | 50.3M | 50.4M | 50.8M | 50.9M |
Diluted Shares Outstanding | 50.1M | 50.9M | 51.6M | 50.8M | 52.6M |